Tuberculous granulomatous infection of the urinary tract is a rare complication of intravesical Bacille Calmette-Guérin (BCG) immunotherapy, which is commonly used for superficial urothelial cell carcinoma of the bladder. We present a case of tuberculous prostatic abscess in a patient who had undergone intravesical BCG immunotherapy for bladder carcinoma in situ. ( 
Fig. 1.
Ultrasonogram shows a small focal anechoic lesion at right transitional zone.
Intravesical Bacille Calmette-Guerin (BCG) instillation therapy for superficial transitional cell carcinoma of the bladder is commonly used and is generally safe. However, this therapy may rarely be complicated by tuberculous granulomatous infection of the urinary tract. We report a case of a prostatic abscess related to intravesical BCG therapy for carcinoma in situ with a brief review of the literature.
CASE REPORT
A 63-year-old man was evaluated for a week's dysuria and microscopic hematuria. There were no notable findings in his medical and family history. His physical examination was Two cases of tuberculous prostatic abscess that developed after BCG therapy were found through a review of the literature.
The first reported case was a transitional cell carcinoma of the bladder accompanied by carcinoma in situ. Forty-four months after diagnosis of carcinoma in situ, perineal pain developed and the patient was on BCG maintenance therapy. The diagnosis of prostatic abscess was confirmed by CT, and the patient was treated by transperineal drainage. 5 The second case was a recurrent carcinoma in situ. Symptoms appeared 5 weeks after BCG therapy, and digital rectal examination aroused suspicion of a prostatic abscess. Without further radiologic workup, the patient was treated by transurethral prostatic resection. 6 Anti-tuberculosis drugs were administered after the operation in both cases, for 12 and 9 months, respectively.
Considering the increased usage of BCG therapy for superficial transitional cell carcinoma, it is important to recognize the possibility of this tuberculous prostatic infection in cases with localized or voiding symptoms.
